MFSD2A and metabolic dysfunction-associated steatotic liver disease: It is interesting to consider that upregulation of Mfsd2a in periportal hepatocytes in response to dietary challenge limits periportal pathology in humans, in which pericentral pathology is the norm in adults with NAFLD and NASH (53, 54).